Nezulcitinib (TD-0903) vs Placebo (RCT)

Hospitalized patients

FOREST PLOTS -2022-10-07

Studies description

Trial NCT04402866
Publication NCT04402866, Unpublished (2022) (results posted on registry)

Funding: Not reported/unclear
Conflict of interest: *

Trial NCT04402866; EudraCT 2020-001807-18
Publication Singh D, medRxiv (2021) (preprint)

Funding: Private (Theravance Biopharma Ireland Limited ; Theravance Biopharma US, Inc.)
Conflict of interest: Yes